> Dobos emphasized to me that she thinks the FDA’s strict regulation of sunscreen products is generally beneficial to the American public, but that the agency’s

> Dobos emphasized to me that she thinks the FDA’s strict regulation of sunscreen products is generally beneficial to the American public, but that the agency’s slow progress on new ingredients doesn’t match the urgency of skin cancer’s threat to public health. This line is where this got interesting to me, as it's not hard to find examples of the US being lax with product/chemical safety compared to Europe in other areas, so I was skeptical of a case to be more rash in this area. So pairing it with the issue of skin cancer makes it more compelling. But they still gloss over chemical absorption in this article, which is a factor that seems like it could use more investigation per https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759112/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759112/ (tldr: sunscreen -> less skin cancers seems well supported, but effect of chemicals in body is not understood).